[Quantitative mycelial growth and antibiotic biosynthesis patterns in actinomycete producers of heliomycin]. 1981

L S Kozhevina, and K A Vinogradova

The quantitative regularities of the mycelium growth and antibiotic biosynthesis were studied in submerged cultures of the heliomycin-producing organisms. The following regularities of the mycelium growth were observed: the growth of the growth tubes proceeds according to the exponential law (the first exponential phase of the culture growth), the growth of separate branching hyphae submits to the linear dependence, the total length of the branching mycelium increases exponentially (the second phase of the culture exponential growth). During the first exponential phase the specific rate of the antibiotic biosynthesis is equal to the specific rate of the mycelium growth and the synthesis of heliomycin balanced with the mycelium growth. During the second exponential phase the specific rate of heliomycin biosynthesis exceeds the specific growth rate which is evident of the antibiotic overproduction. The changes in the ratio of the specific growth rate and antibiotic biosynthesis coincide with the changes in the intracellular localization of heliomycin. When the synthesis of heliomycin is balanced with the culture growth, the antibiotic is in the form showing yellow luminescence. With the beginning of the antibiotic overproduction heliomycin in the form of granules with bright orange luminescence is detected in the mycelium along with the yellow luminescence form. It is suggested that formation of the granules during the antibiotic overproduction is one of the mechanisms of the antibiotic excess removal.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011083 Polycyclic Compounds Compounds which contain two or more rings in their structure. Compounds, Polycyclic
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013171 Spores, Bacterial Heat and stain resistant, metabolically inactive bodies formed within the vegetative cells of bacteria of the genera Bacillus and Clostridium. Bacterial Spores,Bacterial Spore,Spore, Bacterial
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.

Related Publications

L S Kozhevina, and K A Vinogradova
January 1976, Folia microbiologica,
L S Kozhevina, and K A Vinogradova
February 2017, Biotechnology letters,
L S Kozhevina, and K A Vinogradova
April 1985, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
L S Kozhevina, and K A Vinogradova
June 2021, Naunyn-Schmiedeberg's archives of pharmacology,
L S Kozhevina, and K A Vinogradova
January 2022, Evidence-based complementary and alternative medicine : eCAM,
L S Kozhevina, and K A Vinogradova
January 2023, Evidence-based complementary and alternative medicine : eCAM,
L S Kozhevina, and K A Vinogradova
June 2021, Journal of industrial microbiology & biotechnology,
Copied contents to your clipboard!